Harnisch, K.; Teuber-Hanselmann, S.; Macha, N.; Mairinger, F.; Fritsche, L.; Soub, D.; Meinl, E.; Junker, A.
Myelination in Multiple Sclerosis Lesions Is Associated with Regulation of Bone Morphogenetic Protein 4 and Its Antagonist Noggin. Int. J. Mol. Sci. 2019, 20, 154.
https://doi.org/10.3390/ijms20010154
AMA Style
Harnisch K, Teuber-Hanselmann S, Macha N, Mairinger F, Fritsche L, Soub D, Meinl E, Junker A.
Myelination in Multiple Sclerosis Lesions Is Associated with Regulation of Bone Morphogenetic Protein 4 and Its Antagonist Noggin. International Journal of Molecular Sciences. 2019; 20(1):154.
https://doi.org/10.3390/ijms20010154
Chicago/Turabian Style
Harnisch, Kim, Sarah Teuber-Hanselmann, Nicole Macha, Fabian Mairinger, Lena Fritsche, Daniel Soub, Edgar Meinl, and Andreas Junker.
2019. "Myelination in Multiple Sclerosis Lesions Is Associated with Regulation of Bone Morphogenetic Protein 4 and Its Antagonist Noggin" International Journal of Molecular Sciences 20, no. 1: 154.
https://doi.org/10.3390/ijms20010154
APA Style
Harnisch, K., Teuber-Hanselmann, S., Macha, N., Mairinger, F., Fritsche, L., Soub, D., Meinl, E., & Junker, A.
(2019). Myelination in Multiple Sclerosis Lesions Is Associated with Regulation of Bone Morphogenetic Protein 4 and Its Antagonist Noggin. International Journal of Molecular Sciences, 20(1), 154.
https://doi.org/10.3390/ijms20010154